Ludwig researchers describe how acidity turns oxygen-starved cancer cells dormant and drug resistant—and a potentially easy way reverse the effect.
A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which cells enter a state of dormancy as tissues starved of oxygen become increasingly acidic. The study, led by Chi Van Dang, scientific director of the Ludwig Institute for Cancer Research, has potentially significant implications for cancer therapy: Large swaths of solid tumors are often deprived of oxygen, and cells in such patches are thought to be a major source of drug resistance and disease relapses.
Published today in the journal Cell, the study details how in response to acidity cells turn off a critical molecular switch known as mTORC1 that, in ordinary conditions, gauges the availability of nutrients before giving cells the green light to grow and divide. That event, Dang and his colleagues show, shuts down the cell’s production of proteins, disrupting their metabolic activity and circadian clocks, and pushing them into a quiescent state. They also demonstrate that this acid-mediated effect might be relatively easy to reverse—a finding that could help improve a variety of cancer therapies.
“In tumors grafted into mice, we see mTOR activity in spotty places where there’s oxygen,” says Dang who is also a professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute. “But if you add baking soda to the drinking water given to those mice, the entire tumor lights up with mTOR activity. The prediction would be that by reawakening these cells, you could make the tumor far more sensitive to therapy.”
Baking soda had previously been reported to enhance cancer immunotherapy by one of the co-authors of the new study, Robert Gillies of the H. Lee Moffitt Cancer Center, though the mechanism underlying the effect was unclear.
Dang’s team, including co-corresponding author Zandra Walton, an MD-PhD student at the University of Pennsylvania Perelman School of Medicine, discovered that mechanism through an intricate series of experiments done at the University of Pennsylvania and Dang’s Ludwig lab at the Wistar Institute. It centers on the behavior of lysosomes—a sack-like cellular organelle that digests proteins and that mTOR moves to when it is ready for action.
The researchers show that in acidic conditions protein motors propel lysosomes carrying mTOR away from the area around the nucleus, where they’re ordinarily located. This separates mTOR from a protein required for its activation, RHEB, which continues to hang around at that location. Lacking one of its key activation signals, mTOR remains dormant, suspending the synthesis of proteins—including the components of the cell’s molecular clock—along with most metabolic activity.
“Cells don’t want to make proteins or other biomolecules when they’re under stress,” says Dang. “They want to slow things down and only awaken when things return to normal.”
The researchers show that baking soda can reverse this effect. When given to mice in their drinking water, it surprisingly sufficed to neutralize the acidity of hypoxic patches in tumors. This sent lysosomes zipping back to the nuclear periphery in cells—where RHEB was waiting—and restored the activity of mTOR.
All this is relevant to cancer because researchers have long known that quiescent cells cannot typically be killed by chemotherapy. Notably, Dang and his team also found that T cell activation, which is essential to most immunotherapies, is similarly compromised under acidic conditions.
“We started out with a question about oxygen starvation and the circadian clock, and we ended up discovering a new mechanism by which acidic conditions in tissues shut off a lot of things—including the cell’s molecular clock,” muses Dang.
The finding that something as simple as baking soda could possibly help reverse this effect and render quiescent cancer cells susceptible to cancer therapies excites Dang.
“The concept is so easy,” he says. “It’s not some $100,000 per year drug. It’s literally just baking soda.” Dang and his team are now looking into how acidity might affect immunotherapy and further exploring the acid-induced quiescence of cancer cells.
Learn more: HOW MIGHT BAKING SODA BOOST CANCER THERAPY?
Receive an email update when we add a new CANCER THERAPY article.
The Latest on: Cancer therapy
via Google News
The Latest on: Cancer therapy
ViewRay Announces FDA 510(k) Clearance for Advancements in MRI and Functional Imaging Technologies for MRIdian MRI-Guided Radiation Therapy System
on February 21, 2019 at 2:41 am
Potential reduction in treatment delivery time through enhanced MLC speed "Today we announce another significant step forward in our drive to better treat cancer patients and further differentiate ... […]
Cervical cancer could be eradicated by 2100
on February 21, 2019 at 2:27 am
It is believed that the high mortality rate from cervical cancer could be dramatically reduced through prevention, early diagnosis, and effective screening and treatment programs. Lead author of the s... […]
Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib
on February 20, 2019 at 4:00 pm
We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies are being developed in an effort to bring improved ... […]
on February 20, 2019 at 4:00 pm
Sir, Feb. 21 -- I am 52 years of age and resident of Gawalmandi, Lahore. I have been visiting Shaukat Khanum for the past seven months since I was diagnosed with Renal Cell Carcinoma. I was scared and ... […]
New 'smart drug' shows promise for metastatic triple-negative breast cancer
on February 20, 2019 at 2:02 pm
"There's an unmet need for patients with metastatic triple-negative breast cancer, and we see significant tumor shrinkage with this new therapy," Kalinsky adds. Triple-negative breast cancer is an ... […]
Cervical cancer could be eliminated in most countries by 2100, study finds
on February 20, 2019 at 1:13 pm
The viruses are very common and many people experience no symptoms and need no treatment. However, some strains of HPV can lead to genital warts or eventually cancer. © 2019 CBS Interactive Inc. All R... […]
Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing
on February 20, 2019 at 9:19 am
Developed by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody ther... […]
PCPs Discuss Cancer Therapy With Patients, Despite 'Gaps'
on February 20, 2019 at 6:59 am
The life of a US primary care provider (PCP) may be busy, complex, and underpaid. But, according to new research, a substantial minority will nonetheless find time to help their patients with decision... […]
The Role of Neoadjuvant Therapy in Pancreatic Cancer
on February 19, 2019 at 1:16 pm
Davendra Sohal, MD, MPH: So preoperative chemo is, of course, what we are moving toward. The rationale behind this approach is that we use early aggressive chemotherapy regimens—FOLFIRINOX, gem [gemci... […]
via Bing News